美国 · SEC FORM 4
Amylyx Pharmaceuticals, Inc.
AMLX · Nasdaq · CIK 0001658551 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
21 同一窗口内观察到的 Form 4 交易行
13 sales · 7 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-05-21 · Firestone Karen.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -19.4%
- 3M
- +54.6%
- 6M
- +85.9%
- 12M
- —
波动率与流动性
- 波动率
- 87.7%
- Beta
- -0.12
- 平均每日成交额
- USD 64.4M
估值
- 市值
- USD 3.5B
- P/E
- —
基本面
- 利润率
- 0.0%
- ROE
- -47.4%
- 细分行业
- Drug Manufacturers—Specialty & Generic
市场数据
价格数据截至：2026-10-03 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · 来自 Yahoo Finance：市值, 利润率 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 12,666,971
- 上期报告
- 13,512,753
- 日均成交量
- 1,382,131
- 回补天数
- 9.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Firestone Karen | 买入 (P) | Common Stock | 3,800 | USD 13.51 | USD 51,338 | SEC 申报 ↗ |
| 2025-12-23 | Firestone Karen | 买入 (P) | Common Stock | 8,100 | USD 12.45 | USD 100,845 | SEC 申报 ↗ |
| 2025-03-20 | Zeiher Bernhardt G | 买入 (P) | Common Stock | 10,000 | USD 3.70 | USD 37,000 | SEC 申报 ↗ |
| 2024-09-12 | FRATES JAMES M | 买入 (P) | Common Stock | 40,000 | USD 2.53 | USD 101,200 | SEC 申报 ↗ |
| 2024-09-05 | Firestone Karen | 买入 (P) | Common Stock | 50,000 | USD 2.13 | USD 106,500 | SEC 申报 ↗ |
| 2024-09-03 | MILNE GEORGE M JR | 买入 (P) | Common Stock | 100,000 | USD 2.20 | USD 220,000 | SEC 申报 ↗ |
| 2024-05-15 | Quimi Daphne | 买入 (P) | Common Stock | 2,250 | USD 1.89 | USD 4,252 | SEC 申报 ↗ |
| 2024-05-14 | Quimi Daphne | 买入 (P) | Common Stock | 2,750 | USD 1.89 | USD 5,198 | SEC 申报 ↗ |
| 2023-12-15 | Firestone Karen | 买入 (P) | Common Stock | 4,000 | USD 14.97 | USD 59,880 | SEC 申报 ↗ |
| 2023-03-16 | Firestone Karen | 买入 (P) | Common Stock | 1,000 | USD 31.99 | USD 31,990 | SEC 申报 ↗ |
| 2022-01-11 | MVIL, LLC; Morningside Venture Investments Ltd | 买入 (P) | Common Stock | 263,158 | USD 19.00 | USD 5,000,002 | SEC 申报 ↗ |
| 2022-01-11 | Morningside Venture Investments Ltd | 买入 (P) | Common Stock | 263,158 | USD 19.00 | USD 5,000,002 | SEC 申报 ↗ |
| 2022-01-11 | HALVORSEN OLE ANDREAS; Ott David C.; Shabet Rose Sharon; VIKING GLOBAL INVESTORS LP; Viking Global Opportunities GP LLC; Viking Global Opportunities Illiquid Investments Sub-Master LP; Viking Global Opportunities Parent GP LLC; Viking Global Opportunities Portfolio GP LLC | 买入 (P) | Common Stock | 2,300,000 | USD 19.00 | USD 43,700,000 | SEC 申报 ↗ |
| 2022-01-06 | Olinger Margaret | 买入 (P) | Common Stock | 6,842 | USD 19.00 | USD 129,998 | SEC 申报 ↗ |
| 2022-01-06 | MILNE GEORGE M JR | 买入 (P) | Common Stock | 26,315 | USD 19.00 | USD 499,985 | SEC 申报 ↗ |
Form 4 申报证据
50 transaction lines in the latest 365-day window; 247 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | MILNE GEORGE M JR | 卖出 (S) | Common Stock | 30,000 | USD 27.70 | USD 830,904 | SEC 申报 ↗ |
| 2026-09-10 | Mazzariello Gina | 卖出 (S) | Common Stock | 9,536 | USD 32.46 | USD 309,548 | SEC 申报 ↗ |
| 2026-09-10 | Klee Justin B. | 卖出 (S) | Common Stock | 30,464 | USD 32.18 | USD 980,290 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | MILNE GEORGE M JR | 卖出 (S) | Common Stock | 30,000 | USD 27.70 | USD 830,904 | SEC 申报 ↗ |
| 2026-09-10 | Mazzariello Gina | 卖出 (S) | Common Stock | 9,536 | USD 32.46 | USD 309,548 | SEC 申报 ↗ |
| 2026-09-10 | Klee Justin B. | 卖出 (S) | Common Stock | 30,464 | USD 32.18 | USD 980,290 | SEC 申报 ↗ |
| 2026-09-10 | FRATES JAMES M | 卖出 (S) | Common Stock | 10,810 | USD 32.36 | USD 349,839 | SEC 申报 ↗ |
| 2026-09-10 | Cohen Joshua B | 卖出 (S) | Common Stock | 30,464 | USD 32.19 | USD 980,632 | SEC 申报 ↗ |
| 2026-09-10 | Bedrosian Camille L | 卖出 (S) | Common Stock | 10,028 | USD 32.39 | USD 324,833 | SEC 申报 ↗ |
| 2026-08-31 | Firestone Karen | 期权行权／转换 (M) | Common Stock | 50,000 | USD 3.40 | USD 170,250 | SEC 申报 ↗ |
| 2026-08-18 | Mazzariello Gina | 奖励／授予 (A) | Common Stock | 21,284 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-18 | Klee Justin B. | 奖励／授予 (A) | Common Stock | 60,039 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-18 | FRATES JAMES M | 奖励／授予 (A) | Common Stock | 22,807 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-18 | Cohen Joshua B | 奖励／授予 (A) | Common Stock | 60,039 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-18 | Bedrosian Camille L | 奖励／授予 (A) | Common Stock | 22,807 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-10 | Mazzariello Gina | 卖出 (S) | Common Stock | 15,000 | USD 17.61 | USD 264,150 | SEC 申报 ↗ |
| 2026-07-09 | Mazzariello Gina | 卖出 (S) | Common Stock | 15,000 | USD 18.32 | USD 274,800 | SEC 申报 ↗ |
| 2026-05-21 | Firestone Karen | 买入 (P) | Common Stock | 3,800 | USD 13.51 | USD 51,338 | SEC 申报 ↗ |
| 2026-03-05 | Mazzariello Gina | 奖励／授予 (A) | Common Stock | 74,660 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | Klee Justin B. | 奖励／授予 (A) | Common Stock | 248,865 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | FRATES JAMES M | 奖励／授予 (A) | Common Stock | 95,990 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | Cohen Joshua B | 奖励／授予 (A) | Common Stock | 248,865 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | Bedrosian Camille L | 奖励／授予 (A) | Common Stock | 95,990 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Mazzariello Gina | 卖出 (S) | Common Stock | 6,844 | USD 14.52 | USD 99,375 | SEC 申报 ↗ |
| 2026-03-02 | Klee Justin B. | 卖出 (S) | Common Stock | 29,282 | USD 14.47 | USD 423,711 | SEC 申报 ↗ |
| 2026-03-02 | FRATES JAMES M | 卖出 (S) | Common Stock | 7,909 | USD 14.52 | USD 114,839 | SEC 申报 ↗ |
| 2026-03-02 | Cohen Joshua B | 卖出 (S) | Common Stock | 29,282 | USD 14.48 | USD 424,003 | SEC 申报 ↗ |
| 2026-03-02 | Bedrosian Camille L | 卖出 (S) | Common Stock | 6,461 | USD 14.58 | USD 94,201 | SEC 申报 ↗ |
| 2026-02-23 | Mazzariello Gina | 卖出 (S) | Common Stock | 3,419 | USD 14.14 | USD 48,345 | SEC 申报 ↗ |
| 2026-02-02 | Mazzariello Gina | 卖出 (S) | Common Stock | 3,448 | USD 14.65 | USD 50,513 | SEC 申报 ↗ |
| 2026-02-02 | Klee Justin B. | 卖出 (S) | Common Stock | 15,500 | USD 14.69 | USD 227,695 | SEC 申报 ↗ |
| 2026-02-02 | FRATES JAMES M | 卖出 (S) | Common Stock | 3,557 | USD 14.65 | USD 52,110 | SEC 申报 ↗ |
| 2026-02-02 | Cohen Joshua B | 卖出 (S) | Common Stock | 15,500 | USD 14.68 | USD 227,540 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | AMLX |
| CIK | 0001658551 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 247 transaction lines from 2022-01-06 to 2026-10-05 17 P purchase lines · 137 S sale lines · 93 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.